|

GM103 and Pembrolizumab (Part C) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • GeneMedicine Co., Ltd.1

Indications

  • Renal Cell Carcinoma1
  • Malignant Melanoma1
  • Head and Neck Cancer1
  • Colorectal Cancer1
  • Cervical Cancer1

Other1 trial

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.